http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2708490-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42797a9e0ab774c95ce778326c780a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1ffff87b486e57185578f17157c0ad8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_663d7af4811ffadef028a71c38683ab5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec5e854b692028e566f0914c2cc2126c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_872176d7f6658ad4325aaa9a13c7d4d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db8760f11b27d2b63e540eaa292a8ee2
publicationDate 2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2708490-C2
titleOfInvention Method of combined non-invasive treatment of urinary incontinence in patients after radical prostatectomy
abstract FIELD: medicine.SUBSTANCE: method refers to medicine, namely to therapy, and can be used for combined non-invasive treatment of urinary incontinence in patients after radical prostatectomy. Solifenacin is prescribed in dose of 5 mg day for 1 month. Simultaneously with a course of therapy soliphenacin 10 courses of the BFB-therapy are prescribed. During the session, the active external electrodes on the right and left are installed on the perianal area for recording EMG activity of the pelvic floor muscles. Two external electrodes are placed on the anterior abdominal wall and two electrodes – on the area of the crest of pelvic bones. First, the required muscle groups are identified by performing a test electric stimulation for 7–10 minutes and 20-minute session of the BFB-therapy. A regimen aimed at contracting the pelvic floor muscles is selected depending on the pain threshold of the patient.EFFECT: method provides non-invasive treatment of urinary incontinence due to simultaneous use of solifenacin and biofeedback therapy.1 cl, 2 dwg, 2 tbl, 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2778605-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2804515-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2760618-C2
priorityDate 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2499585-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006102029-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009076565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2526400-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154059
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID98923
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID98923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590977

Total number of triples: 29.